IRulya Therapeutics (IRLA) EBIT (2018 - 2026)
IRulya Therapeutics (IRLA) reported EBIT of -$79.78 million for Q2 2026, compared with -$10.43 million a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) EBIT (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, IRulya Therapeutics' EBIT came in at -$127.16 million; for FY2025, it came in at -$58.07 million.
- By year, EBIT came in at -$57.29 million in FY2024, -$34.62 million in FY2023, -$52.02 million in FY2022 and -$90.32 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBIT in data going back to Q1 2018.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$14.59 million (Q1 2026), -$19.35 million (Q4 2025) and -$13.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | -79.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.78 Mn |
| Mar 31, 2026 | -14.59 Mn |
| Dec 31, 2025 | -19.35 Mn |
| Sep 30, 2025 | -13.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | -14.86 Mn |
| Dec 31, 2024 | -12.01 Mn |
| Sep 30, 2024 | -5.86 Mn |
| Jun 30, 2024 | -28.19 Mn |
| Mar 31, 2024 | -11.22 Mn |
| Dec 31, 2023 | -9.92 Mn |
| Sep 30, 2023 | -6.09 Mn |
| Jun 30, 2023 | -5.58 Mn |
| Mar 31, 2023 | -12.96 Mn |
| Dec 31, 2022 | -6.32 Mn |
| Sep 30, 2022 | -7.62 Mn |
| Jun 30, 2022 | -16.26 Mn |
| Mar 31, 2022 | -21.86 Mn |
| Dec 31, 2021 | -23.54 Mn |
| Sep 30, 2021 | -21.68 Mn |
API Access
IRulya Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();